QIAGEN launches complete Sample to Insight workflow for microbiome research
Venlo, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research.
- Venlo, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research.
- Gaining prominence in recent years, microbiome research explores the relationships between microorganisms such as bacteria, fungi and viruses, and their hosts.
- “Our Microbiome WGS SeqSets provide a complete Sample to Insight solution that combines our industry-leading extraction technology with easy-to-use downstream NGS library preparation and intuitive bioinformatics.
- More information on the Sample to Insight workflow for microbiome researchers can be found here: https://www.qiagen.com/applications/microbiome/workflow